Table 2.
Clinicopathologic profiles and detection of circulating tumor cells in 32 patients with hepatocellular carcinoma
| Patient ID | Age/sex | Tumor size, cm | Portal vein tumor thrombus | TNM | CTCs, n |
| 1 | 70/M | > 5 | + | IV | 56 |
| 2 | 49/M | > 5 | + | III | 72 |
| 3 | 27/M | > 5 | - | III | 29 |
| 4 | 51/M | < 5 | - | I | 11 |
| 5 | 49/M | > 5 | + | IV | 108 |
| 6 | 48/F | < 5 | + | III | 43 |
| 7 | 53/M | > 5 | + | IV | 47 |
| 8 | 64/M | > 5 | + | III | 87 |
| 9 | 47/F | > 5 | + | IV | 92 |
| 10 | 62/M | > 5 | + | III | 51 |
| 11 | 35/F | < 5 | - | I | 0 |
| 12 | 42/F | < 5 | - | II | 23 |
| 13 | 57/M | < 5 | - | II | 26 |
| 14 | 41/F | < 5 | - | II | 23 |
| 15 | 71/M | > 5 | + | III | 72 |
| 16 | 37/M | < 5 | - | II | 15 |
| 17 | 47/F | < 5 | - | I | 13 |
| 18 | 65/M | > 5 | - | III | 33 |
| 19 | 65/M | < 5 | - | I | 5 |
| 20 | 63/M | > 5 | + | IV | 67 |
| 21 | 46/F | < 5 | - | II | 29 |
| 22 | 43/M | < 5 | - | II | 9 |
| 23 | 48/M | < 5 | - | I | 0 |
| 24 | 37/M | > 5 | + | III | 50 |
| 25 | 35/F | > 5 | + | III | 38 |
| 26 | 56/F | < 5 | - | II | 56 |
| 27 | 77/F | < 5 | - | II | 17 |
| 28 | 49/M | < 5 | - | II | 29 |
| 29 | 58/M | < 5 | - | I | 0 |
| 30 | 38/M | > 5 | + | III | 50 |
| 32 | 75/F | < 5 | - | II | 22 |
| 32 | 74/M | < 5 | - | II | 28 |
Tumor-node-metastasis stage (TNM) staging from the Sixth Edition of the International Union Against Cancer.